UV Dosimetry Feedback in NMSC Patients
| Status: | Recruiting |
|---|---|
| Conditions: | Skin Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 12/7/2018 |
| Start Date: | March 12, 2018 |
| End Date: | December 2023 |
| Contact: | Sarah Roberts |
| Email: | sarah.roberts@ucdenver.edu |
| Phone: | 303-724-3912 |
UV Dosimetry Feedback in Non-Melanoma Skin Cancer Patients
This study aims to characterize UV exposures among NMSC patients (those with a history of
skin cancer) and to pilot an innovative behavioral intervention to decrease modifiable UV
exposures. It will use UV dosimeters to objectively measure UV exposure and provide time and
activity specific UV data on an individual level. These data will be used to develop a
targeted and personalized behavioral feedback plan with counseling aimed at effective sun
exposure behavior change
skin cancer) and to pilot an innovative behavioral intervention to decrease modifiable UV
exposures. It will use UV dosimeters to objectively measure UV exposure and provide time and
activity specific UV data on an individual level. These data will be used to develop a
targeted and personalized behavioral feedback plan with counseling aimed at effective sun
exposure behavior change
The study will focus on helping to prevent NMSC and its associated morbidity through learning
when patients are unintentionally exposed to extreme UV radiation. It will then help to
create manageable and realistic behavioral interventions to reduce exposure, while also
educating patients of the dangers of abundant sun exposure.
when patients are unintentionally exposed to extreme UV radiation. It will then help to
create manageable and realistic behavioral interventions to reduce exposure, while also
educating patients of the dangers of abundant sun exposure.
Inclusion Criteria:
- Patients between ages 18 and 50.
- Must be diagnosed with non-melanoma skin cancer.
Exclusion Criteria:
- Patients, who at the discretion of the clinician, are too ill or sick.
- Non-English speaking patients.
We found this trial at
1
site
Aurora, Colorado 80045
Principal Investigator: Myles Cockburn, PhD
Phone: 303-724-3912
Click here to add this to my saved trials
